134 related articles for article (PubMed ID: 22850919)
1. [Nutritional status and food intake of continuous peritoneal dialysis patients with and without secondary hyperparathyroidism].
Campos SR; Gusmão MH; Almeida AF; Pereira LJ; Sampaio LR; Medeiros JM
J Bras Nefrol; 2012 Jun; 34(2):170-7. PubMed ID: 22850919
[TBL] [Abstract][Full Text] [Related]
2. Foods contributing to nutrients intake and assessment of nutritional status in pre-dialysis patients: a cross-sectional study.
Seo YK; Lee H; Kim H; Kim TY; Ryu H; Ju DL; Jang M; Oh KH; Ahn C; Han SN
BMC Nephrol; 2020 Jul; 21(1):301. PubMed ID: 32711448
[TBL] [Abstract][Full Text] [Related]
3. Nutritional status of hemodialysis patients with secondary hyperparathyroidism.
Rezende LT; Cuppari L; Carvalho AB; Canziani ME; Manfredi SR; Cendoroglo M; Sigulem DM; Draibe SA
Braz J Med Biol Res; 2000 Nov; 33(11):1305-11. PubMed ID: 11050660
[TBL] [Abstract][Full Text] [Related]
4. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels.
Sutton D; Higgins B; Stevens JM
J Ren Nutr; 2007 Sep; 17(5):329-35. PubMed ID: 17720102
[TBL] [Abstract][Full Text] [Related]
5. Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis.
Tapiawala S; Vora H; Patel Z; Badve S; Shah B
J Assoc Physicians India; 2006 Dec; 54():923-6. PubMed ID: 17334008
[TBL] [Abstract][Full Text] [Related]
6. The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism.
Alfieri C; Regalia A; Zanoni F; Vettoretti S; Cozzolino M; Messa P
Blood Purif; 2019; 47(1-3):37-44. PubMed ID: 30223271
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficiency of treatment with cinacalcet of haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism.
Kuczera P; Adamczak M; Więcek A
Endokrynol Pol; 2013; 64(3):176-81. PubMed ID: 23873419
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
Li W; Zhang S
Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
[TBL] [Abstract][Full Text] [Related]
10. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Elias RM; Moysés RMA
Int Urol Nephrol; 2017 Oct; 49(10):1815-1821. PubMed ID: 28695313
[TBL] [Abstract][Full Text] [Related]
11. Nutritional status in stage V dialyzed patient versus CKD patient on conservative therapy across different economic status.
Vijayan M; Abraham G; Alex ME; Vijayshree N; Reddy Y; Fernando E; Mathew M; Nair S; Yuvaraj A
Ren Fail; 2014 Apr; 36(3):384-9. PubMed ID: 24456000
[TBL] [Abstract][Full Text] [Related]
12. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
Isakova T; Anderson CA; Leonard MB; Xie D; Gutiérrez OM; Rosen LK; Theurer J; Bellovich K; Steigerwalt SP; Tang I; Anderson AH; Townsend RR; He J; Feldman HI; Wolf M;
Nephrol Dial Transplant; 2011 Apr; 26(4):1258-65. PubMed ID: 21382989
[TBL] [Abstract][Full Text] [Related]
13. Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism.
Kuczera P; Adamczak M; Machnik G; Okopien B; Wiecek A
Nephron; 2018; 139(4):286-292. PubMed ID: 29879701
[TBL] [Abstract][Full Text] [Related]
14. Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels.
Zhao Y; Zhang LL; Ding FX; Cao P; Qi YY; Wang J
Ren Fail; 2017 Nov; 39(1):159-165. PubMed ID: 27876426
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD.
Lu CL; Yeih DF; Hou YC; Jow GM; Li ZY; Liu WC; Zheng CM; Lin YF; Shyu JF; Chen R; Huang CY; Lu KC
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513912
[TBL] [Abstract][Full Text] [Related]
16. Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.
Bozic M; Diaz-Tocados JM; Bermudez-Lopez M; Forné C; Martinez C; Fernandez E; Valdivielso JM
Nephrol Dial Transplant; 2022 Mar; 37(4):663-672. PubMed ID: 34021359
[TBL] [Abstract][Full Text] [Related]
17. Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study.
Filipozzi P; Ayav C; Ngueyon Sime W; Laurain E; Kessler M; Brunaud L; Frimat L
BMJ Open; 2017 Mar; 7(3):e011482. PubMed ID: 28348181
[TBL] [Abstract][Full Text] [Related]
18. Influence of Pre-renal Transplant Secondary Hyperparathyroidism on Later Evolution After Transplantation.
Garcia-Montemayor V; Sánchez-Agesta M; Agüera ML; Calle Ó; Navarro MD; Rodríguez A; Aljama P
Transplant Proc; 2019 Mar; 51(2):344-349. PubMed ID: 30879538
[TBL] [Abstract][Full Text] [Related]
19. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
Suwan N
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K
J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
